These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 9625910)
1. Treatment of visceral leishmaniasis with sodium stibogluconate in Sudan: management of those who do not respond. Khalil EA; el Hassan AM; Zijlstra EE; Hashim FA; Ibrahim ME; Ghalib HW; Ali MS Ann Trop Med Parasitol; 1998 Mar; 92(2):151-8. PubMed ID: 9625910 [TBL] [Abstract][Full Text] [Related]
2. A comparison of liposomal amphotericin B with sodium stibogluconate for the treatment of visceral leishmaniasis in pregnancy in Sudan. Mueller M; Balasegaram M; Koummuki Y; Ritmeijer K; Santana MR; Davidson R J Antimicrob Chemother; 2006 Oct; 58(4):811-5. PubMed ID: 16916865 [TBL] [Abstract][Full Text] [Related]
3. Antimony-induced cerebellar ataxia. Khalil EA; Ahmed AE; Musa AM; Hussein MH Saudi Med J; 2006 Jan; 27(1):90-2. PubMed ID: 16432602 [TBL] [Abstract][Full Text] [Related]
4. Leishmania donovani: an in vitro study of antimony-resistant amphotericin B-sensitive isolates. Sharief AH; Gasim Khalil EA; Theander TG; Kharazmi A; Omer SA; Ibrahim ME Exp Parasitol; 2006 Dec; 114(4):247-52. PubMed ID: 16716301 [TBL] [Abstract][Full Text] [Related]
5. [Treatment of visceral leishmaniasis in children]. Minodier P; Noël G; Blanc P; Uters M; Retornaz K; Garnier JM Med Trop (Mars); 2007 Feb; 67(1):73-8. PubMed ID: 17506279 [TBL] [Abstract][Full Text] [Related]
6. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar. Das VN; Ranjan A; Bimal S; Siddique NA; Pandey K; Kumar N; Verma N; Singh VP; Sinha PK; Bhattacharya SK Natl Med J India; 2005; 18(3):131-3. PubMed ID: 16130613 [TBL] [Abstract][Full Text] [Related]
7. Clinical, haematological and parasitological response to treatment of visceral leishmaniasis in Kenya. A study of 64 patients. Kager PA; Rees PH; Manguyu FM; Bhatt KM; Wellde BT; Hockmeyer WT; Lyerly WH Trop Geogr Med; 1984 Mar; 36(1):21-35. PubMed ID: 6328709 [TBL] [Abstract][Full Text] [Related]
8. A randomized comparison of branded sodium stibogluconate and generic sodium stibogluconate for the treatment of visceral leishmaniasis under field conditions in Sudan. Veeken H; Ritmeijer K; Seaman J; Davidson R Trop Med Int Health; 2000 May; 5(5):312-7. PubMed ID: 10886792 [TBL] [Abstract][Full Text] [Related]
9. Sodium stibogluconate and paromomycin for treating visceral leishmaniasis under routine conditions in eastern Sudan. Atia AM; Mumina A; Tayler-Smith K; Boulle P; Alcoba G; Elhag MS; Alnour M; Shah S; Chappuis F; van Griensven J; Zachariah R Trop Med Int Health; 2015 Dec; 20(12):1674-84. PubMed ID: 26427033 [TBL] [Abstract][Full Text] [Related]
10. Cure of antimony-unresponsive Indian visceral leishmaniasis with amphotericin B lipid complex. Sundar S; Murray HW J Infect Dis; 1996 Mar; 173(3):762-5. PubMed ID: 8627049 [TBL] [Abstract][Full Text] [Related]
11. Comparison of treatment regimens of kala-azar based on culture & sensitivity of amastigotes to sodium antimony gluconate. Thakur CP; Thakur S; Narayan S; Sinha A Indian J Med Res; 2008 Jun; 127(6):582-8. PubMed ID: 18765878 [TBL] [Abstract][Full Text] [Related]
12. Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome. Ritmeijer K; Veeken H; Melaku Y; Leal G; Amsalu R; Seaman J; Davidson RN Trans R Soc Trop Med Hyg; 2001; 95(6):668-72. PubMed ID: 11816442 [TBL] [Abstract][Full Text] [Related]
14. Leishmania species, drug unresponsiveness and visceral leishmaniasis in Bihar, India. Thakur CP; Dedet JP; Narain S; Pratlong F Trans R Soc Trop Med Hyg; 2001; 95(2):187-9. PubMed ID: 11355558 [TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial. Omollo R; Alexander N; Edwards T; Khalil EA; Younis BM; Abuzaid AA; Wasunna M; Njoroge N; Kinoti D; Kirigi G; Dorlo TP; Ellis S; Balasegaram M; Musa AM Trials; 2011 Jun; 12():166. PubMed ID: 21718522 [TBL] [Abstract][Full Text] [Related]
16. Epidemiological, clinical & pharmacological study of antimony-resistant visceral leishmaniasis in Bihar, India. Thakur CP; Narayan S; Ranjan A Indian J Med Res; 2004 Sep; 120(3):166-72. PubMed ID: 15489554 [TBL] [Abstract][Full Text] [Related]
17. Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first-line drug? An observational study of 80 cases. Thakur CP; Sinha GP; Pandey AK; Kumar N; Kumar P; Hassan SM; Narain S; Roy RK Ann Trop Med Parasitol; 1998 Jul; 92(5):561-9. PubMed ID: 9797829 [TBL] [Abstract][Full Text] [Related]
18. Amphotericin B is superior to sodium antimony gluconate in the treatment of Indian post-kala-azar dermal leishmaniasis. Thakur CP; Narain S; Kumar N; Hassan SM; Jha DK; Kumar A Ann Trop Med Parasitol; 1997 Sep; 91(6):611-6. PubMed ID: 9425363 [TBL] [Abstract][Full Text] [Related]
19. A comparative evaluation of amphotericin B and sodium antimony gluconate, as first-line drugs in the treatment of Indian visceral leishmaniasis. Thakur CP; Narayan S Ann Trop Med Parasitol; 2004 Mar; 98(2):129-38. PubMed ID: 15035723 [TBL] [Abstract][Full Text] [Related]
20. Amphotericin B in visceral leishmaniasis. Jha BB Indian Pediatr; 1996 Nov; 33(11):971. PubMed ID: 9141838 [No Abstract] [Full Text] [Related] [Next] [New Search]